Part D: The New Medicare Prescription Drug Law Implications for Medicaid

Similar documents
MEDICARE PRESCRIPTION DRUGS and LOW-INCOME BENEFICIARIES

Alabama Medicaid Pharmacist

2008 Medicare Part D: Pharmacist's Survival Guide. Ronnie DePue, R.Ph., CGP

Figure 1. Medicaid Status of Medicare Beneficiaries, Partial Dual Eligibles (1.0 Million) 3% 15% 83% Medicare Beneficiaries = 38.

WORKING WITH PRIVATE SECTOR PARTNERS TO MAXIMIZE MEDICARE SAVINGS PROGRAM AND PART D ENROLLMENT

The Impact of the Medicare Prescription Drug Legislation on Pharmaceutical Revenues

Brief Overview of Medicare Part D and Part C

WikiLeaks Document Release

MEDICAID AND BUDGET RECONCILIATION: IMPLICATIONS OF THE CONFERENCE REPORT

DEFICIT REDUCTION ACT OF 2005: IMPLICATIONS FOR MEDICAID PREMIUMS AND COST SHARING CHANGES

Provisions of the Medicare Modernization Act

Medicare. Medicare? What does it have to do with me? Alan Farkas, M.S., R.Ph.

MEDICARE PART D PRESCRIPTION DRUG PROGRAM BASICS

Medicare: The Basics

IMPLICATIONS OF THE MEDICARE MODERNIZATION ACT FOR STATES:

Medicare Modernization Act and Medicare Part D: Status of Implementation

Deprescribing. Medicare 101. Deprescribing. Webinar #9 Webinar #1. Jessica Visco, PharmD, CGP SeniorPharmAssist. Jessica Visco, PharmD, CGP

An Overview of the Medicare Part D Prescription Drug Benefit

Low Medicaid Spending Growth Amid Rebounding State Revenues. Results from a 50-State Medicaid Budget Survey State Fiscal Years 2006 and 2007

PACE & Medicare Part D

PLAN DESIGN AND BENEFITS PROVIDED BY AETNA LIFE INSURANCE COMPANY

A Side-by-Side Comparison of Selected Medicare Prescription Drug Coverage Proposals

Benefits and Premiums are effective January 01, 2018 through December 31, 2018 PLAN DESIGN AND BENEFITS PROVIDED BY AETNA LIFE INSURANCE COMPANY

Understanding Private- Sector Medicare

PRESCRIPTION DRUG PLANS. What is a PDP?

Medicare and Patient Assistance

Medicare Part D: TrOOP (True Out-Of-Pocket) Costs

2017 Medicare Advantage and Prescription Drug Overview. Module 2

Public Sector Plans: Medicare & Medicaid

Medicare Part D Drug Benefit and HIV/AIDS Care. Mary R. Vienna Deputy Director, HRSA/HAB/DTTA Rockville, Maryland

uninsured A MEDICAID PERSPECTIVE ON PART D IMPLEMENTATION; THE MEDICARE PRESCRIPTION DRUG PROGRAM

uninsured Medicaid Today; Preparing for Tomorrow A Look at State Medicaid Program Spending, Enrollment and Policy Trends

An extensive network of pharmacies. Choose from over 60,000 retail pharmacies in our national network you are sure to find your favorite one.

Coordinating the Medicare Modernization Act with State Pharmacy Assistance Programs: A State-Level Perspective

and the uninsured February 2006 Medicare-Medicaid Policy Interactions

Medicare Updates. Illinois Department on Aging Senior Health Insurance Program (SHIP)

Medicare Modernization Act (MMA)

Medicare Advantage: Program Overview and Recent Experience. James Cosgrove, Ph.D. Director, Health Care U.S. Government Accountability Office

The Fundamentals of Medicare. Jim Hahn, CRS National Health Policy Forum February 11, 2011

Medicare Minute Teaching Materials - June 2018 How to Afford Your Part D Drug Costs

2017 Medicare Part D Low-Income Subsidy (LIS) Income and Resource Standards

MEDICARE PART D PRESCRIPTION DRUG BENEFIT

Medicare Part D Amounts Will Increase in 2015

Medicaid and Access To Care: Implications of DRA. Donna A. Boswell November Be Careful What You Wish For

Medicare Part D. William J. Hogan American National Insurance Company

The Pharmacy Coverage Safety Net: Variations in State Responses to Supplement Medicare Part D

Patient Out-of-Pocket Assistance in Medicare Part D: Direct and Indirect Healthcare Savings

Figure 1. Differences in Out-of-Pocket Expenses for Poor Beneficiaries in the House and Senate Low-Income Subsidy Programs $1,200 $150

Chapter 7: Medicare Part D Prescription Drug Coverage in Patients With CKD

MEDICARE PRESCRIPTION DRUG LEGISLATION: Part D Benefits and Employer Subsidies. December 2003

The Impact of the Medicare Prescription Drug Benefit on State Programs

Medicare Part D: What Are The Concerns?

Texas Vendor Drug Program. Pharmacy Provider Procedure Manual Coordination of Benefits. Effective Date. February 2018

Medicare Payment Advisory Commission (MedPAC) January Meeting Summary

The Patient Protection and Affordable Care Act of Enacted March, 2010

Closing the Coverage Gap Medicare Prescription Drugs are Becoming More Affordable

An Overview of Medicare

Making It Work: State Leadership on Medicare Rx Implementation and Coordinating with State Pharmacy Assistance Programs

Closing the Coverage Gap Medicare Prescription Drugs Are Becoming More Affordable

Medicare Overview Employer Options and Trends

Implementing the Medicare Drug Benefit. Robert Donnelly Director, Medicare Drug Benefit Group June 8, 2005

John R. Kasich, Governor Jillian Froment, Director. Welcome to Medicare

Choosing Between Traditional Medicare and Medicare Advantage

Federal Spending on Brand Pharmaceuticals. April 2011

MEDICARE PART D PRESCRIPTION DRUG EVENTS (PDE) RECONCILIATION

Melissa Scarborough, MPH, CHES Centers for Medicare & Medicaid Services Dallas Regional Office

THE MEDICARE R x DRUG LAW

Kathy Hoffman Kory Koehnen

Medicare Part D Prescription Drug Benefit

2017 Medicare Basics. Module 1

Exploring the Interaction between Medicare Part B and Medicare Part D

An Advocate s Guide to AIDS Drug Assistance Program (ADAP) & Medicare Part D: Understanding the Decisions Every Program Must Make

Medicare Part D In Massachusetts: Successes and Continuing Challenges. Cindy Parks Thomas Massachusetts Health Policy Forum May 30, 2007

Keystone 65 Part D Rider An Addendum to Your Evidence of Coverage

MEDICARE PART D FROM A TO Z. Your comprehensive guide to prescription drug coverage. A PUBLICATION OF:

5/5/2014. The Affordable Care Act* 45 th Annual WMSHP Spring Seminar. The Affordable Care Act (ACA) March 23,2010

On Nov. 15, open enrollment returns and Year Two brings new questions and answers.

THE MEDICARE R x DRUG LAW. The Impact of Enrollment in the Medicare Prescription Drug Benefit on Premiums

Introduction to Medicare Parts C and D

Part D Low Income Subsidy Lis Extra Help Income

2019 Medicare Part D

Express Scripts Medicare Prescription Drug Plan (PDP) for EIA

The Medicaid Landscape

Oklahoma Health Care Authority

uninsured Moving Ahead Amid Fiscal Challenges: A Look at Medicaid Spending, Coverage and Policy Trends

TOWN OF WINCHESTER Aetna Medicare Rx Plan Custom RX $10/$25/$50/$50. Benefits and Premiums are effective January 01, 2019 through December 31, 2019

Medicare and the New Health Care Law

Farm Bureau Select Rx 2017 Summary of Benefits January 1, December 31, 2017

Proposed Changes to Medicare in the Path to Prosperity Overview and Key Questions

Medicare Part D Prescription Drug Coverage 2006 RBC Changes

Health Care Reform & Medicare: The Basics (and a little more) Leslie Fried, Esq. ABA Commission on Law & Aging

ASSISTING MEDICARE PATIENTS THE ROLE OF THE PHARMACIST WITH LIMITED INCOME:

Medicare Part D. What Pharmacists Need to Know to Navigate Through 2006 and Beyond

Your New Medicare Prescription Drug Benefit

Medicare Part D. Prescription Drug Insurance Coverage

Introduction to the Use of Medicare Data for Research. Marshall McBean, M.D., M.Sc. Director of ResDAC University of Minnesota

Welcomes Electric Boat Employees & Spouses to our Medicare SOS Workshop

Medicare 101 Nov. 9, Greg Burn

(PDP) 2014 Summary of benefits for our Medicare prescription drug plans (Enhanced and Standard)

summary of benefits Blue Shield of California Medicare Rx Plan (PDP)

Transcription:

Part D: The New Medicare Prescription Drug Law Implications for Medicaid Vernon K. Smith, Ph.D. HEALTH MANAGEMENT ASSOCIATES For State Coverage Initiatives National Meeting Washington, D.C. February 4, 2005 vsmith@healthmanagement.com 1 Medicare Prescription Drug, Improvement, and Modernization Act MMA Public Law 108-173 of 2003 Drug discount card for 2004 and 2005 Part D prescription drug benefit beginning 2006 Many other changes, such as: Increased Medicare payments for hospitals, physicians, & health plans Created Medicare Advantage to replace Medicare + Choice (i.e., managed care plans) Created Health Savings Accounts Estimated Cost: $400 billion (by the CBO) to $553 billion (by the HHS) over 10 years from 2004-2013 2 1

States Have Much at Stake in the New Medicare Drug Benefit Prescription drugs for low-income Medicare beneficiaries ( Dual Eligibles ) have been a major Medicaid cost The MMA mandates that Medicaid drug coverage for Part D drugs for Duals end on January 1, 2006 The transition from Medicaid to Medicare for 6.4 million dual eligibles must be quick and perfect to avoid potential loss of coverage and harm to beneficiaries 3 Medicaid s Role in the U.S. Health System Medicaid was 19% of national prescription drug spending in 2003, the nation s largest single purchaser of prescription drugs 46% 17% 17% 12% 19% Total Personal Health Care Hospital Care Professional Services Nursing Home Care Prescription Drugs Total National Spending (billions) $1,441 $516 $542 $111 $179 SOURCE: Smith, et al, 2005. Based on National Health Care Expenditure Data, CMS, Office of the Actuary. 4 2

Almost Half of Medicaid Spending for Prescription Drugs Is for Duals Drug Spending on Dual Eligibles 48% ($11.3 Billion) 52% ($12.1 Billion) Drug Spending on Other Groups Total Medicaid Rx Spending = $23.4 Billion SOURCE: Urban Institute estimates prepared for KCMU based on MSIS data for FFY2000 and Form 64 FFY2002 data. Data reflect expenditures on outpatient prescription drugs only and are net of Medicaid rebates. 5 Medicare Part D : Basic Facts for the Standard Benefit Enrollment:... Voluntary Initial enrollment period:... 6 months: 11-15-05 to 5-15-06 Annual enrollment periods: Nov. 15 to Dec. 31 Coverage will begin:. Jan. 1, 2006 Premiums in 2006.. $35 per month (Estimated) Those who don t enroll initially, or who don t maintain continuous coverage, will pay higher premiums 6 3

Part D Prescription Drug Plans The Part D benefit will be administered primarily by risk-bearing private plans: Prescription Drug Plans (PDPs) Medicare Advantage Prescription Drug plans (MA-PDs) Federal non-risk fall-back plan (only if needed) Beneficiaries can choose from at least 2 plans. The plan chosen will determine which drugs are covered and the price for drugs The Federal government is prohibited from negotiating prices for PDPs & MA-PDs. 7 Part D Plans Must Cover Drugs In Every Class But Not All Drugs Will include at least 2 drugs in all 209 drug classes Will exclude certain drugs, such as those for: Weight loss or weight gain, fertility Cosmetic or hair growth Cough or cold relief Vitamins and minerals Over-the-counter (OTCs) available without a prescription Valium, Ativan, Phenobarital (benzodiazepines & barbiturates) Drugs covered under Medicare Parts A or B 8 4

Beneficiary Premiums Beneficiary premiums will be a percentage of submitted bids and will vary from plan to plan. Federal subsidy of premiums will be 74.5%. Beneficiaries will pay premiums set at 25.5% of average bid, +/- the plan bid less the average bid. Plan Bids $130 $135 $140 Nat l Weighted Avg $135 Premium $30 $35 $40 9 Part D Standard Benefit in 2006: Beneficiary Coverage & Out-of-Pocket Drug Costs Catastrophic Coverage 5% Medicare Pays 95% BENEFICIARY OUT-OF-POCKET SPENDING No Coverage $2,850 Gap ( Donut Hole ) $5,100 (Equivalent to $3,600 in out-of-pocket spending) Partial Coverage Up to a Limit 25% DEDUCTIBLE $2,250 (The initial coverage limit ) $250 +~$420 IN ANNUAL PREMIUMS SOURCE: Adapted from The Henry J. Kaiser Family Foundation, Medicare Fact Sheet: The Medicare Prescription Drug Law, March 2004. 10 5

Part D Beneficiary Out-Of-Pocket Costs Indexed Projected Increases from 2006 to 2013: Deductible: $250 will go to $445 Donut hole: $2,850 will go to $5,066 Catastrophic threshold: $5,100 will go to $9,600 Growth in Out-of-Pocket Costs Below the Catastrophic Threshold (Excluding Premiums) $8,000 $6,000 $4,000 $2,000 $3,600 + Premium $6,400 + Premium $0 2006 2007 2008 2009 2010 2011 2012 2013 Deductible 25% Coinsurance Doughnut Hole 11 SOURCE: Congressional Budget Office letter to the Honorable Don Nickles, November 20, 2003. Part D Will Be Very Helpful for Beneficiaries with Low-Incomes Discounted or zero premiums, deductibles and coinsurance No donut hole gap in coverage Must be on Medicaid or qualify with both an income and asset test Vernon Smith, Kathleen Gifford, Sandy Kramer, Implications of the Medicare Modernization Act for States: Observations from a Focus Group Discussion with Medicaid Directors, Kaiser Commission on Medicaid and the Uninsured, January 2005. Available at: http://www.kff.org/medicaid/7248.cfm 12 6

Part D Subsidies are Means-Tested Based on Income (as a Percentage of the Federal Poverty Level) and Assets Household Size Individual 100% FPL $9,310 Percentage of the 2004 Federal Poverty Level 135% FPL $12,569 150% FPL $13,965 Couple $12,490 $16,862 $18,735 NOTE: Federal Poverty Levels change each year. SOURCE: Federal Register. Vol. 69, No. 30, February 13, 2004, pp. 7336 7338. 13 Part D Partial Low-Income Subsidies Non-Medicaid Beneficiaries Incomes Up to 150% FPL FPL in 2004: $13,965 (individual) $18,735 (couple) Asset Test: $10,000 (individual) $20,000 (couple) ----------------------------------------------------------------- Premium: $1 to $34 based on income Deductible: $50 Coinsurance: 15% before catastrophic threshold Donut Hole: None 14 Catastrophic: $2 for generics and $5 for brands 7

Part D Full Low-Income Subsidy Non-Medicaid Beneficiaries Incomes Up to 135% FPL FPL in 2004: $12,568 (individual) $16,862 (couple) Asset Test: $6,000 (individual) or $9,000 (couple) ------------------------------------------------------------------- Premium: $0 Deductible: $0 Copayment: $2 for generics and $5 for brands before catastrophic threshold Donut Hole: None 15 Catastrophic: No copayments Part D Low-Income Subsidy Beneficiaries on Medicaid Dual Enrollees Premium: $0 Deductible: $0 Copayments:* $1 for generics & $3 for brands below 100% FPL $2 for generics and $5 for brands at & above 100% FPL $0 copay, if institutionalized Donut Hole: None Catastrophic: $0 copay * Beyond 2006, copays are indexed 16 8

More Than One-Third of Medicare Beneficiaries Will Qualify for the Low-Income Drug Subsidy in 2006 Eligible for Part D Subsidy--- (14.2 million) 36% --- Ineligible due to income > 150% poverty 59% (23.8 million) Income <150% poverty, But ineligible due to assets-- (1.8 million) 5% Medicare Part B Beneficiaries = 39.9 Million SOURCE: Congressional Budget Office cost estimates, July 2004. Due to rounding, data do not sum to 39.9 million. 17 Characteristics of 14 Million Subsidy-Eligible Individuals, 2006 Non-Duals Eligible For Partial Subsidy (1.9 million) 13% 45% Dual Eligible, Full Part D Subsidy (6.4 million) Non-Duals Eligible For Full Subsidy (6.0 million) 42% Subsidy Eligible Individuals = 14.2 Million SOURCE: KCMU analysis of CBO s cost estimate of the Medicare prescription drug benefit, July 2004. Due to rounding, data do not sum to 14.2 million. 18 9

State Issue 1: Can Dual Eligibles Be Transitioned to Medicare in Time? Timeframe is very short: Information on PDPs will become known in September 2005 All Dual Eligibles will be auto-enrolled CMS is committed to assuring no gap in coverage CMS expects auto enrollment of duals before initial enrollment period Duals will be assigned to a benchmark or lower-premium plan Unlike others on Medicare, Duals can switch plans in any given month, not just annually Medicaid officials concern: a complex process involving 6.4 million duals must be perfect Source: Vernon Smith, Kathleen Gifford, Sandy Kramer, Implications of the Medicare Modernization Act for States: Observations from a Focus Group Discussion with Medicaid Directors, Kaiser Commission on Medicaid and the Uninsured, January 2005. Available at: http://www.kff.org/medicaid/7248.cfm 19 State Issue 2: What If PDP Coverage Is Less Comprehensive than Medicaid? Medicaid coverage is comprehensive Most states use Preferred Drug Lists (PDLs) formularies outlawed Prior authorization process is quick Appeals process is quick on exceptions to coverage or limits PDPs may use formularies comparable to employersponsored drug coverage CMS regulations shortened the appeals process, but still not did not require an emergency supply during the appeal like Medicaid CMS regulations require a transition process for individuals whose drugs are not covered by the PDP (details are not yet available) PDPs will not have access to Medicaid clinical information Some states expect pressure to wrap-around Medicare coverage if beneficiaries cannot get current medications Source: Vernon Smith, Kathleen Gifford, Sandy Kramer, Implications of the Medicare Modernization Act for States: Observations from a Focus Group Discussion with Medicaid Directors, Kaiser Commission on Medicaid and the Uninsured, January 2005. 20 Available at: http://www.kff.org/medicaid/7248.cfm 10

State Issue 3: How Will States Carry Out Their Role in Administering Part D? Beginning in July 2005, regulations require states to take applications for the Part D Subsidy States must develop the capacity to process applications States must offer applicants the opportunity to apply for Medicaid if they appear to be eligible States fear that key information they need to develop policies and systems is not available with enough time to make the needed changes States do not have additional staff or systems resources (beyond 50% federal administrative match) Source: Vernon Smith, Kathleen Gifford, Sandy Kramer, Implications of the Medicare Modernization Act for States: Observations from a Focus Group Discussion with Medicaid Directors, Kaiser Commission on Medicaid and the Uninsured, January 2005.Available at: 21 http://www.kff.org/medicaid/7248.cfm State Issue 4: Will Low-Income Subsidies Increase the Number of Dual Eligibles? The Part D benefit is much more comprehensive and costs less for individuals below 150% of the Federal Poverty Level Low-income Medicare beneficiaries will have a strong incentive to apply for subsidies State officials are concerned about the higher costs they will incur for more Duals: Part A and B premiums, deductibles, coinsurance, and other benefits not covered by Medicare. Source: Vernon Smith, Kathleen Gifford, Sandy Kramer, Implications of the Medicare Modernization Act for States: Observations from a Focus Group Discussion with Medicaid Directors, Kaiser Commission on Medicaid and the Uninsured, January 2005. 22 Available at: http://www.kff.org/medicaid/7248.cfm 11

State Issue 5: Will State Costs Increase or Decrease? New administrative costs for taking applications for low-income subsidies More low-income Medicare beneficiaries will enroll in Medicaid as dual eligibles Diminished Medicaid market share will mean less ability to negotiate supplemental manufacturer rebates Loss of prescription drug paid claims information to use for disease management Potential costs of wrapping around The Clawback Source: Vernon Smith, Kathleen Gifford, Sandy Kramer, Implications of the Medicare Modernization Act for States: Observations from a Focus Group Discussion with Medicaid Directors, Kaiser Commission on Medicaid and the Uninsured, January 2005. 23 Available at: http://www.kff.org/medicaid/7248.cfm State Issue 6: The Clawback Phased-Down State Contribution States are concerned: States sending the federal government money to help pay for a federal benefit is a troubling precedent States are concerned: The Clawback formula is flawed The 2003 base year will not reflect 2006 The base reflects a Medicaid benefit likely more comprehensive than that offered by a PDP National index to inflate the 2003 base to 2006 does not account for state actions to control costs of drugs, or audits or recoveries The Clawback goes forever it phases down but never phases out Most states expect no savings and many expect the clawback to cause state costs to increase Source: Vernon Smith, Kathleen Gifford, Sandy Kramer, Implications of the Medicare Modernization Act for States: Observations from a Focus Group Discussion with Medicaid Directors, Kaiser Commission on Medicaid and the Uninsured, January 2005. 24 Available at: http://www.kff.org/medicaid/7248.cfm 12

Clawback Formula Multiply: 1 Per Capita Monthly Amount A 1/12th CY 03 Rx Payments Full-Benefit CY03 Duals Clawback Basics x B State Match Rate [1-FMAP] For Clawback Month x C Mfg Rebate Percent x D U.S. Growth Factor X X 2 Full-Benefit Duals Enrolled in Month 3 Monthly Factor Adjustment Clawback Total Amount For a month in: 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 & After Factor 90% 88.33% 86.67% 85% 83.33% 81.67% 80% 78.33% 76.67% 75% 25 Medicaid Prescription Drug Policy Changes FY 2004 and FY 2005 FY 2004 FY 2005 More Rx Under Prior Authorization 21 33 Preferred Drug List 29 27 New or Lower State MAC Rates 16 21 Seek Supplemental Rebates 19 26 New or Higher Copays 3 15 AWP Less Greater Discount 8 8 Reduce Dispensing Fee 3 7 SOURCE: Vernon Smith, Rekha Ramesh, Kathleen Gifford, Eileen Ellis, Robin Rudowitz and Molly O Malley, The Continuing Medicaid Budget Challenge: State Medicaid Spending Growth and Cost Containment in Fiscal Years 2004 and 2005, Kaiser Commission on Medicaid and the Uninsured, October 2004. 26 13

Other Key Issues: Beneficiary Copayments & Nursing Home Patients Part D copayments are set nationally Dual eligibles [in our state] have no cost sharing for pharmacy. Under Part D, cost sharing will be required. Nursing home patients under Part D present a difficult challenge Source: Health Management Associates interviews of State Medicaid Directors, for Kaiser Commission on Medicaid and the Uninsured, July and August 2004. 27 States Must Be Prepared for Medicare Part D Transition Issues Beneficiaries may call Medicaid, the Governor, their Legislator or Member of Congress if they Discover a gap in coverage if they do not enroll by January 1, 2006 Don t know how to use plan Find that the drug Medicaid covered isn t covered by their PDP Have higher out-of-pocket costs for copays or noncovered drugs Pharmacists and prescribers will have to assist millions of beneficiaries with potentially new Rx coverages, copay rules, and billing rules Source: Focus group discussion with Medicaid directors conducted by Health Management Associates 28 for Kaiser Commission on Medicaid and the Uninsured, November 2004 14

Conclusion States must be ready for significant change under Part D Assure a perfect transition of duals from Medicaid to Medicare Prepare to accept, process, forward applications for low-income subsidies to SSA Calculate and budget for monthly Clawback payments to federal government beginning January 2006. Prepare to work with legislators and other policy makers to assure state resources Deal with the inevitable issues that arise with a complex change Ongoing CMS guidance & interpretation of MMA will affect ultimate impact. Source: Vernon Smith, Kathleen Gifford, Sandy Kramer, Implications of the Medicare Modernization Act for States: Observations from a Focus Group Discussion with Medicaid Directors, Kaiser Commission on Medicaid and the Uninsured, January 2005. Available at: http://www.kff.org/medicaid/7248.cfm 29 15